Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8652354 | The Annals of Thoracic Surgery | 2018 | 24 Pages |
Abstract
In an enhanced national dataset representative of outcomes for stage IA NSCLC, sublobar resection was associated with a 39% increased risk of cancer recurrence. The majority of patients treated with sublobar resection had an inadequate lymph node assessment. These real-world results must be considered when existing clinical trial results comparing these treatments are extrapolated for clinical use.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Melanie MD, Timothy PhD, Bryan F. MD, MPH, Varun MD, MSCI, Benjamin D. MD, MPH,